Xeris Pharmaceuticals Inc (XERS): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 12,857 US Dollar | 5 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 182.320.306 | 4,55 | 2,46 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Xeris Pharmaceuticals Inc
Mitarbeiter 435
Handelsplatz NASDAQ
Ticker Symbol XERS
IPO Datum 2018-06-21
Adresse 1375 West Fulton Street, Chicago, IL, United States, 60607
Webseite https://www.xerispharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. John P. Shannon | Chairman & CEO |
| 2 | Mr. Kevin McCulloch | President & COO |
| 3 | Mr. Steven M. Pieper | Chief Financial Officer |
| 4 | Ms. Beth P. Hecht J.D. | Chief Legal Officer & Corporate Secretary |
| 5 | Dr. Anh T. Nguyen M.B.A., M.D. | Chief Medical Officer |
| 6 | Mr. Brian Conner | SVP of Quality and Chief Compliance & Risk Officer |
| 7 | Ms. Kendal Korte | Senior Vice President of Human Resources |
| 8 | Joshua Bennett | Vice President of Strategy & Business Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 7,97% | 0,16 Mrd. USD |
| 2 | D. E. Shaw & Co LP | 4,28% | 0,08 Mrd. USD |
| 3 | Vanguard Capital Management, LLC | 4,03% | 0,08 Mrd. USD |
| 4 | State Street Corp | 2,64% | 0,05 Mrd. USD |
| 5 | Geode Capital Management, LLC | 2,59% | 0,05 Mrd. USD |
| 6 | Nuveen, LLC | 2,41% | 0,05 Mrd. USD |
| 7 | Rosalind Advisors, Inc. | 1,60% | 0,03 Mrd. USD |
| 8 | Qube Research & Technologies | 1,59% | 0,03 Mrd. USD |
| 9 | Vanguard Portfolio Management, LLC | 1,44% | 0,03 Mrd. USD |
| 10 | Wellington Management Company LLP | 1,30% | 0,03 Mrd. USD |
| 11 | Morgan Stanley - Brokerage Accounts | 1,28% | 0,03 Mrd. USD |
| 12 | Legal & General Group PLC | 1,10% | 0,02 Mrd. USD |
| 13 | Armistice Capital, LLC | 1,07% | 0,02 Mrd. USD |
| 14 | Two Sigma Investments LLC | 1,03% | 0,02 Mrd. USD |
| 15 | Parkman Healthcare Partners LLC | 0,99% | 0,02 Mrd. USD |
| 16 | Algert Global LLC | 0,96% | 0,02 Mrd. USD |
| 17 | Northern Trust Corp | 0,88% | 0,02 Mrd. USD |
| 18 | The Goldman Sachs Group Inc | 0,87% | 0,02 Mrd. USD |
| 19 | AQR Capital Management LLC | 0,85% | 0,02 Mrd. USD |
| 20 | Charles Schwab Investment Management Inc | 0,82% | 0,02 Mrd. USD |